Koshinski Asset Management
CRL icon

Koshinski Asset Management’s Charles River Laboratories CRL Stock Holding History

Koshinski Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,267
Closed -$234K – 636
2024
Q4 		$234K Buy
1,267
+43
+4% +$8.28K 0.02% 556
2024
Q3 		$241K Buy
1,224
+41
+3% +$8.52K 0.02% 542
2024
Q2 		$239K Buy
1,183
+154
+15% +$34.9K 0.02% 515
2024
Q1 		$279K Buy
+1,029
New +$246K 0.03% 451
2023
Q4 		– Sell
-1,034
Closed -$203K – 524
2023
Q3 		$203K Buy
1,034
+2
+0.2% +$411 0.02% 528
2023
Q2 		$217K Sell
1,032
-155
-13% -$30.8K 0.02% 539
2023
Q1 		$240K Buy
1,187
+24
+2% +$5.44K 0.02% 485
2022
Q4 		$253K Sell
1,163
-5
-0.4% -$1.09K 0.02% 500
2022
Q3 		$230K Buy
+1,168
New +$252K 0.03% 468
2022
Q2 		– Sell
-825
Closed -$234K – 843
2022
Q1 		$234K Buy
825
+194
+31% +$59.8K 0.02% 541
2021
Q4 		$238K Buy
631
+243
+63% +$94.4K 0.02% 571
2021
Q3 		$160K Buy
+388
New +$161K 0.01% 678

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Koshinski Asset Management's CRL Position: Q1 2025 in Review

Koshinski Asset Management sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 1,267 shares — an estimated $234K sold.

Koshinski Asset Management first reported a position in CRL in Q3 2021 and held it in 12 quarters. The position peaked at $279K in Q1 2024. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

  • Koshinski Asset Management reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
  • Koshinski Asset Management sold 1,267 Charles River Laboratories shares in Q1 2025, an estimated $234K.
  • Koshinski Asset Management first reported a position in Charles River Laboratories in Q3 2021 and held it in 12 quarters.
  • Koshinski Asset Management's Charles River Laboratories position peaked at $279K in Q1 2024.
  • 561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on Koshinski Asset Management's 13F filing for Q1 2025, filed 25 Apr 2025.